PCYTE news

Latest 1 stories · newest Nov 19, 2026

PCYTE
PharmaCyte exchanges warrants for shares and extends maturity

PharmaCyte Biotech will exchange 851,304 warrants for 4,982,272 shares and has agreed to extend the Series H preferred stock maturity. The extension was secured via the consent of the holder, who controls a majority of the Series H stock.

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same PCYTE feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/PCYTE/newsSTART FREE